FDA Inspection 858117 — Eli Lilly & Company

Eli Lilly & Company — FEI 1819470

The FDA completed an inspection of Eli Lilly & Company on Dec 6, 2013 in Indianapolis, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 6, 2013
Fiscal Year
2014
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Indianapolis, IN (United States)